Phase II Amount
$1,133,112
Disruption of gene regulation is a major causal factor in heritable disease, developmental disorders,and oncogenesis. While chromatin immunoprecipitation followed by sequencing (ChIP-seq) and Tn5-transposase based tagging (Cut&Tag) enable analysis of transcription factor binding and epigenetic stateprofiling in bulk tissue samples and tumor biopsies, they produce only population average signals. Yetregulatory networks and perturbations are heterogeneous between cell classes and types. Single-celltechnologies can overcome the challenge of cellular heterogeneity and provide deeper insight into celltype-specific gene regulatory programs in healthy, diseased, and cancerous tissues. In prior work, wedeveloped a single-cell joint assay of histone modification and RNA expression (Paired-Tag), enablingcell-type-stratified epigenetic profiling from bulk samples. This technology has attracted customers inboth academic and nonprofit research. In the proposed study, we will develop automated protocols andeffect laboratory informatics systems to establish a Paired-Tag services laboratory, we will refine ourprotocol to improve experimental throughput and reduce cost, and we will develop a Paired-Tag "TF"protocol for profiling transcription factor binding profiles. If successful, the research would enable next-generation multi-omic analysis of tumor or disease samples at comparable cost to single-omictechnologies.
Public Health Relevance Statement: We proposed to expand our research laboratory into a Paired-Tag services laboratory by developing
automated protocols and integrating these with a laboratory information management system. We
further proposed to reduce experimental costs by expanding multiplexing and exploring microfluidic
single-cell platforms, to make our novel technology easier to use by publishing our processing and
analysis pipelines, and to expand our technology's impact by adapting it to profile transcription factors.
Project Terms: <µfluidic> | | | | |